Unravelling tumour spatiotemporal heterogeneity using spatial multimodal data
Clinical and Translational Medicine · 2025-05 · 15 (5)
DOI: 10.1002/ctm2.70331 ↗At a glance
Übersichtsarbeit in Clinical and Translational Medicine, published online on 2025-05-07. Written by Chunman Zuo and 3 co-authors. Institution: School of Life Sciences, Sun Yat-sen University, Guangzhou, China. Major MEDLINE topics: Neoplasms. Cited 23 times so far (Crossref); 210 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Natural Science Foundation of China, Science and Technology Commission of Shanghai Municipality, Zhejiang Province Vanguard Goose-Leading Initiative.
Abstract (original language)
Analysing the genome, epigenome, transcriptome, proteome, and metabolome within the spatial context of cells has transformed our understanding of tumour spatiotemporal heterogeneity. Advances in spatial multi‐omics technologies now reveal complex molecular interactions shaping cellular behaviour and tissue dynamics. This review highlights key technologies and computational methods that have advanced spatial domain identification and their pseudo‐relations, as well as inference of intra‐ and inter‐cellular molecular networks that drive disease progression. We also discuss strategies to address major challenges, including data sparsity, high‐dimensionality, scalability, and heterogeneity. Furthermore, we outline how spatial multi‐omics enables novel insights into disease mechanisms, advancing precision medicine and informing targeted therapies. Key points Advancements in spatial multi‐omics facilitate our understanding of tumour spatiotemporal heterogeneity. AI‐driven multimodal models uncover complex molecular interactions that underlie cellular behaviours and tissue dynamics. Combining multi‐omics technologies and AI‐enabled bioinformatics tools helps predict critical disease stages, such as pre‐cancer, advancing precision medicine, and informing targeted therapeutic strategies.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- School of Life Sciences, Sun Yat-sen University, Guangzhou, China.
- Key Laboratory of Systems Biology, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai, China.
- Key Laboratory of Systems Health Science of Zhejiang Province, School of Life Science, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Hangzhou, China.
- West China Biomedical Big Data Center, Med-X Center for Informatics, West China Hospital, Sichuan University, Chengdu, China.
- School of Mathematical Sciences and School of AI, Shanghai Jiao Tong University, Shanghai, China.
ORCID profiles: Chunman Zuo
Funding
- National Natural Science Foundation of China
- Science and Technology Commission of Shanghai Municipality
- Zhejiang Province Vanguard Goose-Leading Initiative
- Hangzhou Institute for advanced study of UCAS
- JST Moonshot R&D
Cite
APA
Zuo, C., Zhu, J., Zou, J., & Chen, L. (2025). Unravelling tumour spatiotemporal heterogeneity using spatial multimodal data. Clinical and Translational Medicine, 15(5). https://doi.org/10.1002/ctm2.70331
Vancouver
Zuo C, Zhu J, Zou J, Chen L. Unravelling tumour spatiotemporal heterogeneity using spatial multimodal data. Clinical and Translational Medicine. 2025;15(5). doi:10.1002/ctm2.70331
BibTeX
@article{Zuo2025,
author = {Zuo, Chunman and Zhu, Junchao and Zou, Jiawei and Chen, Luonan},
title = {Unravelling tumour spatiotemporal heterogeneity using spatial multimodal data},
journal = {Clinical and Translational Medicine},
year = {2025},
volume = {15},
number = {5},
doi = {10.1002/ctm2.70331}
}
EUVIMED